AzTrials
AzTrials

Reconstructive Flap SurgeryNCT06744387

Anterolateral Tigh (ALT) Flaps Oxygenation Monitoring by NIRS

An observational study of Reconstructive Flap Surgery and Fasciocutaneous Anterolateral Thigh Flap, run by University Hospital, Antwerp at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to conduct postoperative monitoring in patients who have undergone upper or lower limb reconstructive surgery with an anterolateral thigh flap, by employing the gold standard approach: intermittent assessment of clinical parameters (flap's color, temperature, skin turgor and… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
clinical assessments and tissue oxygenation monitoring by Near Infrared Spectroscopy
How many people
20 participants
Where
1 siteBelgium
Study dates
3 Mar 2025to 30 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: scheduled for reconstructive flap surgery on either upper or lower limb using a fasciocutaneous anterolateral thigh flap

Who may be able to join

  • scheduled for reconstructive flap surgery on either upper or lower limb using a fasciocutaneous anterolateral thigh flap

Who cannot join

  • refusal to provide written informed consent.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Vera Saldien, MD contact

38214788 ext. +32

vera.saldien@uza.be

Belgium1 site, 1 recruiting
  • Antwerp University Hospital

    Edegem, Antwerp, 2650

    Vera Saldien, MD, PhD, 38214788 ext. 0032, vera.saldien@uza.be

    Joke De Wachter, 38213042 ext. 0032, joke.dewachter@uza.be

    Recruiting

Other trials in Belgium

About this study

Official title: Tissue Oxygenation Monitoring of Anterolateral Thigh (ALT) Flaps, Using FORE-SIGHT ELITE Near InfraRed Spectroscopy (NIRS) - A Pilot Study

The goal of this observational study is to conduct postoperative monitoring in patients who have undergone upper or lower limb reconstructive surgery with an anterolateral thigh flap, by employing the gold standard approach: intermittent assessment of clinical parameters (flap's color, temperature, skin turgor and capillary refill time) combined with Doppler techniques, alongside continuous tissue oxygenation measurements obtained using the CASMED FORE-SIGHT ELITE monitor.The main objective of the study is to provide preliminary data on potential cut-off values indicative of flap failure.

Read the detailed description

Microvascular reconstructive free flap surgery is commonly used practice in contemporary medicine for managing extensive and complex tissue defects. A primary concern associated with this surgical approach is the risk of flap failure during the postoperative phase, usually resulting from vascular compromise in the first 1-3 days after surgery. Minimizing the time interval to revision surgery enhances the likelihood of salvaging the flap. Hence, effective, and vigilant monitoring is crucial in detecting this feared complication. Currently, the gold standard for monitoring entails the assessment of the flap's skin color, temperature, tissue turgor and capillary refill time, usually supplemented by Doppler techniques. This method of monitoring is labor-intensive and reliant on the expertise of the nursing staff, resulting in variability and inconsistencies. There is a definite need for a more objective, real-time monitoring approach, which is attainable through techniques like Near Infrared Spectroscopy (NIRS). NIRS is a non-invasive tool employed in medical settings to assess regional tissue oxygenation through the placement of specific electrodes at the anatomical site of interest. These electrodes emit photons at multiple wavelengths within the near-infrared spectrum (700-1100 nanometer ) into the tissues and subsequently measure the reflected light patterns. Optical properties of biological molecules alter upon oxygen binding, which causes variations in the near-infrared light absorption patterns. Therefore, the absorption pattern is contingent upon the ratio of oxygenated to deoxygenated hemoglobin. Through analysis of these light patterns and the oxygenated-to-deoxygenated hemoglobin ratio, the NIRS monitor calculates and displays a real-time measurement of tissue oxygen saturation (StO2). This number represents the balance between oxygen supply and uptake in the surrounding tissues and offers information on the underlying hemodynamics. With regards to monitoring after reconstructive flap surgery, NIRS currently occupies a limited role and cannot yet replace the established gold standard of clinical assessment and Doppler techniques. This limited use stems primarily from a lack of consensus on the interpretation of the measured values and the question remains which cut-off values or trends should lead to reintervention. Most of the studies did suggest certain cut-off values, nonetheless, a consensus could not be deduced, except for the ViOptix Tissue Oximeter (ViOptix Inc., Fremont, Ca, USA). An StO2 drop rate of more than 20% per hour during more than 30 minutes could be suggestive of vascular crisis when using this device. Overall, authors attributed the discrepancies in published cut-off values to a lack of large randomized clinical trials and to manufacturer-related variations in the devices, such as number of emitted wavelengths, measuring depth and accuracy, analyzing algorithms.

In this pilot study, we aim to conduct postoperative monitoring in patients who have undergone upper or lower limb reconstructive surgery with an anterolateral thigh flap, employing the gold standard approach for flap surgery, combined with Doppler techniques. Alongside continuous tissue oxygenation measurements will be applied using the FORE-SIGHT ELITE tissue oximeter (FORE-SIGHT ELITE, CAS Medical Systems, Branford, CT USA). The measurements by the FORE-SIGHT ELITE however, remain blinded for the patient and the nursing staff. The data are stored in the FORE-SIGHT ELITE device and will be retrieved after the monitoring period of five days by the investigators. The gold standard approach is used to identify cases of flap failure and distinguish them from control subjects. The 'control' group includes patients with successful flap outcomes and reassuring clinical assessments, while the 'case' group consists of patients with abnormal clinical findings and accompanying flap failure.

The anesthetic management during the reconstructive flap surgery will comply with the standard of care. Each patient will be routinely monitored through pulse oximetry, blood pressure measurements and 5-lead electrocardiography. Patients will be put under general anesthesia using sufentanyl or fentanyl combined with a target-controlled infusion (TCI) of propofol. Muscle paralysis will be induced using rocuronium. Depending on the extensiveness of the operation, a second peripheral line and/or an arterial line for invasive blood pressure measurement and arterial blood gas analysis may be placed. Adequate hemodynamic management is crucial in guaranteeing sufficient perfusion of the flap. Inotropes or vasoactive medications may be employed for this purpose. Body temperature will be monitored and normothermia will be maintained. Following preoperative marking of the flap at the anterolateral thigh (donor site) and identification of dominant vascular branches using Doppler ultrasound, the surgical intervention will be performed. At end of surgery the surgeon marks the location of the main vascular anastomosis sites on the flap for postoperative monitoring of Doppler signals. Two sensors, one at the flap site and one at the donor site, will be attached by the surgeon before departure from the operating room to the Post Anesthetic Care Unit (PACU). Depending on the size of the flap, pediatric sensors will be used. After surgery the patient will stay in the PACU for one night. Continuous NIRS tissue oxygenation measurements will commence upon the patient's arrival at the PACU. The first measurement at the PACU will be considered the baseline value. Trained nurses will conduct hourly clinical assessments of skin color, capillary refill, temperature, skin turgor, and Doppler signals for the first 24 hours. In addition, patients will be routinely monitored with pulse oximetry, 3-lead electrocardiography, and blood pressure measurements. Following their stay in the PACU, patients will be transferred to a regular nursing ward, where the clinical assessment of the flap and the patient's vitals signs monitoring will be continued. In the event of an abnormal clinical evaluation, the nurses will promptly notify the surgeon.

Cases of flap failure will be identified by use of the gold standard(skin color, temperature, tissue turgor and capillary refill time measured by Doppler techniques) along with evaluation of clinical assessments of vital signs while NIRS measurements remain blinded. Following the monitoring period of five days, the stored NIRS values and trends in the FORE-SIGHT ELITE device from both groups will undergo analysis and will be compared. The objective is to gain insight into potential cut-off values for detecting vascular compromise.

Being tested
clinical assessments and tissue oxygenation monitoring by Near Infrared Spectroscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • clinical assessments and tissue oxygenation monitoring by Near Infrared SpectroscopyDiagnostic test

    Flap failure will be identified, based upon gold standard monitoring (flaps skin color, temperature, tissue turgor and capillary refill time) along with Doppler technique during a postoperative period of five days. In all patients Near Infrared Spectroscopy (NIRS) by FORE-SIGHT ELITE will be applied to obtain continuous tissue oxygenation measurements. NIRS values and trends from patients with flap failure (case group) will be compared to NIRS values and trends from patients with no flap failure(control group).

Study groups in NCT06744387
Study groupRoleWhat they receive
patients with reconstructive flap surgery on upper or lower limb using a fasciocutanous tigh flapNot described
Receives: Diagnostic Test: clinical assessments and tissue oxygenation monitoring by Near Infrared Spectroscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. provide preliminary data on potential cut-off values for tissue oxygenation indicative for flap failure

    a decrease of x percent in tissue oxygenation below the baseline value (first measurement upon arrival at the PACU) of the anterolateral thigh flap.

    Measured: from end of surgery untill five days after surgery

  2. provide preliminary data on potential cut-off values for tissue oxygenation indicative for flap failure

    a decrease of x percent in tissue oxygenation in the anterolateral thigh flap compared to the reference measurements obtained from the unaffected remaining anterolateral thigh.

    Measured: from end of surgery untill five days after surgery

Secondary outcomes (1)
  1. retrospective time-to-event analysis in patients with flap failure

    a retrospective time-to-event analysis for the index test (NIRS measurements) and the reference test (the gold standard) within the subgroup of cases with flap failure.

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2024
  2. Study start3 Mar 2025
  3. Primary completion30 Nov 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06744387
Sponsor's protocol ID
EDGE 003917
Status last verified
Mar 2025
First submitted
27 Nov 2024
Last updated
5 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Reconstructive Flap Surgery and Fasciocutaneous Anterolateral Thigh Flap, run by University Hospital, Antwerp at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Vera Saldien, MD (38214788 ext. +32, vera.saldien@uza.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

provide preliminary data on potential cut-off values for tissue oxygenation indicative for flap failure (time frame: from end of surgery untill five days after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in